TENCIBAVI

View On IC.GC.CA

REGISTERED

on 10 May 2023

Last Applicant/ Owned by

TAKEDA PHARMACEUTICALS INTERNATIONAL AG

Thurgauerstrasse 130CH-8152 Glattpark-Opfikon

Serial Number

2084024 filed on 11^th Dec 2020

Registration Number

TMA1178980 registered on 10^th May 2023

Registration expiry Date

11^th Dec 2030

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

K1P1C3

TENCIBAVI

Trademark usage description

pharmaceutical preparations for the treatment of post-transplant cytomegalovirus infections.

Classification Information

2084024

Trademark

Action Taken	Status
Submitted for opposition 130 on 13^th Jan 2023	Note to file
Submitted for opposition 22 on 7^th Jun 2022	Search Recorded
Submitted for opposition 20 on 7^th Jun 2022	Examiner's First Report
Submitted for opposition 223 on 7^th Jun 2022	Total Provisional Refusal
Submitted for opposition 256 on 13^th Dec 2021	Notification of Possible Opposition Sent
Submitted for opposition 257 on 11^th Feb 2021	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 10^th Feb 2021	Formalized
Submitted for opposition 1 on 10^th Feb 2021	Created
Submitted for opposition 228 on 11^th Dec 2020	International Registration
Submitted for opposition 30 on 11^th Dec 2020	Filed